Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Kontafarma China, headquartered in Hong Kong, is a prominent player in the real estate services sector, specifically focusing on property management and consultancy. Established in 2005, the company has steadily expanded its operations across major regions in China, establishing a reputation for excellence in service delivery.
Specialising in residential and commercial property management, Kontafarma China distinguishes itself through its commitment to innovative solutions and customer-centric approaches. The firm has achieved significant milestones, including numerous awards for service quality and operational efficiency, solidifying its market position as a trusted partner in the real estate industry.
With a focus on sustainability and technological integration, Kontafarma China continues to lead the way in enhancing property value and tenant satisfaction, making it a key player in the evolving landscape of real estate services.
-13 vs industry average
Kontafarma China’s score of 16 is lower than 32% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Real Estate Services has above-average carbon intensity
The Real Estate Services industry has reduced its overall emissions by 17% since 2018
Scope 3 accounts for ••• of total emissions.
Kontafarma China, a Hong Kong-headquartered real estate services company, has committed to reducing its carbon emissions. While comprehensive emissions data for all scopes is not consistently available across all years, the company has reported some figures.
In 2024, Kontafarma China reported Scope 2 emissions from purchased electricity of 710,000 kg CO2e. This figure was disclosed alongside a broader "scope_1_and_2" total of 1,470,000 kg CO2e, though individual Scope 1 data for this year was not provided. For 2023, the company's Scope 2 emissions from purchased electricity were 727,000 kg CO2e, with an overall "scope_1_and_2" total of 1,057,000 kg CO2e. In 2022, Kontafarma China reported Scope 3 emissions totalling 804,000 kg CO2e, along with an aggregated "scope_1_and_2" total of 2,110,000 kg CO2e, but did not disclose individual Scope 1 or Scope 2 figures for that year.
Earlier data includes 2020, with Scope 1 emissions of 1,375,000 kg CO2e and Scope 2 emissions of 3,913,000 kg CO2e, which included 24,592,000 kg CO2e from purchased electricity. For 2019, Scope 1 emissions were 1,487,000 kg CO2e and Scope 2 emissions were 3,922,000 kg CO2e, including 25,655,000 kg CO2e from purchased electricity.
Kontafarma China has expressed a commitment to creating value in the low-carbon transition and achieving sustainable development through continuous reduction of emissions and resource consumption. The company aims for net-zero, near-term reduction targets for both Scope 1 and Scope 2 emissions between 2023 and 2025, with a target year of 2024. This commitment was noted in a 2025 document from the company. It should be noted that Kontafarma China inherits its performance data from its parent organisation, Kontafarma China Holdings Limited, which is the source for this information.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more